
Penn Path & Lab Medicine
@PennPathLabMed
Followers
3K
Following
825
Media
292
Statuses
5K
Pathology and Laboratory Medicine @Penn: AP, CP, Research, Transfusion Medicine & Therapeutic Pathology, and Precision Dx
Philadelphia, PA
Joined February 2014
Honored to have you on our team Dr. Baloch!.
Honored to be part of this esteemed group of clinicians @AmThyroidAssn @TheAACE @TheEndoSociety @EndoPath @NayarRitu @PennPathLabMed @pathologyfinder @DianaEstherossi @DrJuhlin @bfaquin
0
1
3
RT @PennMedCSO: How future cures begin as ideas in laboratories ft. @carlhjune, @BLLPHD (@PennPathLabMed), David Porter, @StephenBagleyMD,….
0
3
0
RT @PennMedCSO: ft. A. Pawar, P. Somers, A. Alex, J. Grana, V. Feist, @SapanaSubhash, C. Antony, R. Verner, M. Khera, V. Paralkar (@PennCan….
0
1
0
Are you considering a residency in #pathology ? Join us for our annual virtual open house on September 16th to learn more. We cannot wait to meet you and tell you all about our amazing program!
1
12
26
RT @PennMedCSO: ft. Peter Gearhart (@PennOBGYN), @debsfrench (@PennPathLabMed), Kaoru Takasaki, @menjewafula, Jian Fan, Ying Sit, Sara Kuma….
0
2
0
RT @PennMedCSO: Academia & industry form powerful partnerships for impact ft. Carter Caldwell (@PennPCI), Saar Gill (@PennCancer), Michael….
0
2
0
Reminiscing about the wonderful welcome event our Chair @DrNetto hosted for our new class of Residents last month. We are delighted to welcome such an impressive class to our program!
0
2
28
Exciting to see our faculty highlighted in this article from the @phillyinquirer last week! .Check out 'The story behind Dispatch Biotherapeutics, an immunotherapy start-up with Penn roots' 🔬:
inquirer.com
Renowned Penn scientist Carl June and Jeff Marrazzo, founding CEO of Philly's Spark Therapeutics, are part of the leadership that the company that has raised $216 million from investors.
0
1
3
RT @PennMedCSO: In @CurrentBiology, reprogramming of endolysosomes for melanogenesis in BLOC-1-deficient melanocytes ft. @marks_labCHOP (@P….
0
1
0
RT @PennMedCSO: Clinicopathologic characteristics of papillary thyroid carcinoma, tall cell subtype & subtype with tall cell features ft. @….
0
2
0
RT @PennMedCSO: New research out in @natBME uses bioengineered immunocompetent preclinical trial-on-chip tool to enable screening of CAR T….
0
4
0
RT @PennMedCSO: Spatial profiling of chromatin accessibility in formalin-fixed paraffin-embedded tissues ft. Pengfei Guo, @LiranMao, @ChinN….
0
4
0
Congratulations to @LambrisJD on being selected for the International Complement Society's 2025 Legacy Award! 🎉. A fitting honor for such an impressive member of the team. Read more about the award 🔬:
0
0
2
RT @PennMedCSO: ft. @megclarks, Walter Mowel, @MFMich1, Leonel Joannas, @Notorious_MHC, Isabel Erickson, Jorge Henao-Mejia (@PennPathLabMed….
0
8
0
RT @PennMedCSO: ft. Siera Tomishima, Dale Kim, @YohanizOrtega, Paula Oliver (@PennPathLabMed), Robert Bowman (@Penn_CBIO), Nadia Porter, Ip….
0
4
0
RT @PennMedCSO: Temporal & spatial omics technologies for 4D profiling ft. Yoon Ho Roh, Jina Ko (@PennPathLabMed), David Reynolds, Daniel O….
0
2
0
Wonderful to see the work of @ZhiHuangPhD featured so prominently!.
#ICYMI: An AI collaboration framework, developed by @ZhiHuangPhD (@PennPathLabMed) & colleagues, was recently featured on the cover of @natBME
0
1
6